NFKB1 and cancer: By decreasing NF-κB signaling, TECs also lower the expression of cancer cell adhesion molecules, which contributes to metastasis inhibition of cancer cells.104 Thus, targeting EC metabolism through PFKFB3 might offer unprecedented opportunities for anti-angiogenic therapies and inhibition of tumor growth.